Induced Pluripotent Stem Cell (iPSC) Market 2021 Global Size, Status and Outlook- Thermo Fisher Scientific Inc.; Takara Bio Inc.; ViaCyte; Fate Therapeutics

Induced Pluripotent Stem Cell (iPSC) Market 2021 report helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market- driven results deriving feasibility studies for client needs. Market Insights Reports ensures qualified and verifiable aspects of market data operating in the real- time scenario. The analytical studies are conducted ensuring client needs with a thorough understanding of market capacities in the real- time scenario.

SPECIAL OFFER (Avail an Up-to 25% discount on this report, please fill the form and mention the code: MIR30 in the comments section)

Click the link to get a Free Sample Copy of the Report @:

https://www.marketinsightsreports.com/reports/09223281859/induced-pluripotent-stem-cell-ipsc-global-market-opportunities-and-strategies-to-2030-covid-19-growth-and-change-including-1-by-derived-cell-type-hepatocytes-fibroblasts-keratinocytes-amniotic-others-2-by-application-academic-research-drug-discovery-and-toxicity-studies-regenerative-medicine-gene-cell-therapy-3-by-end-user-hospitals-research-laboratories-covering-fujifilm-holding-corporation-thermo-fisher-scientific-inc-takara-bio-inc-viacyte-fate-therapeutics/inquiry?Mode=Saiba

The global induced pluripotent stem cell (iPSC) market reached a value of nearly $2,223.5 million in 2020, having increased at a compound annual growth rate (CAGR) of 9.2% since 2015.

Top leading Companies Profiled in Induced Pluripotent Stem Cell (iPSC) Market Report are Fujifilm Holding Corporation; Thermo Fisher Scientific Inc.; Takara Bio Inc.; ViaCyte; Fate Therapeutics

Markets Segmentation:

1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic; Others

2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Gene & Cell Therapy

3) By End-User: Hospitals; Research Laboratories

Market Overview

The market is expected to grow from $2,223.5 million in 2020 to $3,362.1 million in 2025 at a rate of 8.6%. The market is then expected to grow at a CAGR of 6.2% from 2025 and reach $4,547.7 million in 2030.

Growth in the historic period resulted from increased healthcare spending, rise in funding, aid as non animal alternatives for preclinical trials and increasing demand of personalized medicines. Factor that negatively affected growth in the historic period was lack of awareness on induced pluripotent stem cell.

Going forward, increasing prevalence of chronic diseases, growth genomic projects, development in iPSC models, increasing funding and increasing prevalence of genetic diseases. Factors that could hinder the growth of the induced pluripotent stem cell (iPSC) market in the future include risk associated with it and high costs associated with storage.

The induced pluripotent stem cell (iPSC) market is segmented by application into drug discovery and toxicity studies, academic research, cell & gene therapy, and regenerative medicine. The drug discovery and toxicity studies was the largest segment of the induced pluripotent stem cell (iPSC) market segmented by application, accounting for 48.7% of the total in 2020. Going forward, cell & gene therapy segment is expected to be the fastest growing segment in the induced pluripotent stem cell (iPSC) market segmented by application, at a CAGR of 9.82% during 2020-2025.

The induced pluripotent stem cell (iPSC) market is also segmented by end-user into hospitals and research laboratories. The research laboratories was the largest segment of the induced pluripotent stem cell (iPSC) market segmented by end-user, accounting for 68.5% of the total in 2020. Going forward, the hospitals segment is expected to be the fastest growing segment in the induced pluripotent stem cell (iPSC) market segmented by end-user, at a CAGR of 9.3% during 2020-2025.

The induced pluripotent stem cell (iPSC) market is also segmented by derived cell type into amniotic, hepatocytes, fibroblasts, keratinocytes and others. The fibroblasts was the largest segment of the induced pluripotent stem cell (iPSC) market segmented by derived cell type, accounting for 33.0% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the induced pluripotent stem cell (iPSC) market segmented by derived cell type, at a CAGR of 10.0% during 2020-2025.

Get Benefited discount at:

https://www.marketinsightsreports.com/reports/09223281859/induced-pluripotent-stem-cell-ipsc-global-market-opportunities-and-strategies-to-2030-covid-19-growth-and-change-including-1-by-derived-cell-type-hepatocytes-fibroblasts-keratinocytes-amniotic-others-2-by-application-academic-research-drug-discovery-and-toxicity-studies-regenerative-medicine-gene-cell-therapy-3-by-end-user-hospitals-research-laboratories-covering-fujifilm-holding-corporation-thermo-fisher-scientific-inc-takara-bio-inc-viacyte-fate-therapeutics/discount?Mode=Saiba

Regional Analysis

North America was the largest region in the induced pluripotent stem cell (iPSC) market, accounting for 49.8% of the total in 2020. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the induced pluripotent stem cell (iPSC) market will be Africa and Asia- Pacific, where growth will be at CAGRs of 15.7% and 15.4% respectively. These will be followed by South America, and Middle East where the markets are expected to grow at CAGRs of 13.7% and 12.4% respectively.

The induced pluripotent stem cell (iPSC) market is fragmented, with a large number of players constituting the market. The top ten competitors in the market made up to 26% of the total market in 2020. Major players in the market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc Takara Bio Inc., ViaCyte, and Fate Therapeutics.

The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by derived cell type will arise in the fibroblasts segment, which will gain $360.1 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by end-user industry will arise in the hospitals segment, which will gain $393.0 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by application will arise in the drug discovery and toxicity studies segment, which will gain $520.3 million of global annual sales by 2025. The induced pluripotent stem cell (iPSC) market size will gain the most in the USA at $132.6 million.

Key Takeaways from Induced Pluripotent Stem Cell (iPSC) Report

─Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals

─Understand the different dynamics influencing the Induced Pluripotent Stem Cell (iPSC) market – key driving factors, challenges and hidden opportunities.

─Get in-depth insights on your competitor performance – Induced Pluripotent Stem Cell (iPSC) market shares, strategies, financial benchmarking, product benchmarking, SWOT and more

─Analyze the sales and distribution channels across key geographies to improve top-line revenues.

─Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

─Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

─Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the Induced Pluripotent Stem Cell (iPSC)

Buy Now This Report at

https://www.marketinsightsreports.com/report/purchase/09223281859?mode=su?Mode=Saiba

In conclusion, the Induced Pluripotent Stem Cell (iPSC) market report presents the descriptive analysis of the parent market supported elite players, present, past and artistic movement information which is able to function as a profitable guide for all the Induced Pluripotent Stem Cell (iPSC) Industry business competitors. Our expert research analyst’s team has been trained to provide in-depth market research reports from every individual sector which will be helpful to understand the industry data in the most precise way.

Available Customization– The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234
Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.